Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02972216 | Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy | completed | — | 40 | Yung Shin Pharm. Ind. Co., Ltd.INDUSTRY | 0 | Nov 23, 2016 | clinicaltrials |
| NCT02963896 | Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma(ITG) | completed | N/A | 20 | University Hospital, MotolOTHER | 0 | Nov 15, 2016 |
| clinicaltrials |
| NCT00581360 | Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck | completed | Phase 2 | 10 | University of PittsburghOTHER | 1 | Nov 7, 2016 | clinicaltrials |
| NCT00439426 | A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. | completed | Phase 2 | 25 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00723463 | Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue | completed | Early Phase 1 | 200 | University of MichiganOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01577173 | A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 11 | Nov 2, 2016 | clinicaltrials |
| NCT01540136 | Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 3 | 402 | Sun Yat-sen UniversityOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01681654 | Exercise and Nutrition for Head and Neck Cancer Patients(ENHANCE) | completed | N/A | 60 | University of CalgaryOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT02007200 | Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Oct 24, 2016 | clinicaltrials |
| NCT02597582 | LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients | completed | Phase 4 | 41 | Taichung Veterans General HospitalOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02937610 | Percutaneous Endoscopic Gastrostomy in Hands of ORL-HN Surgeon | completed | — | 127 | University of HelsinkiOTHER | 0 | Oct 18, 2016 | clinicaltrials |
| NCT00281866 | Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer | completed | Phase 2 | 37 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Oct 12, 2016 | clinicaltrials |
| NCT00101582 | Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer | completed | Phase 3 | 188 | Swedish Orphan BiovitrumINDUSTRY | 0 | Sep 27, 2016 | clinicaltrials |
| NCT00310115 | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | completed | — | 469 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT01921426 | A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck | completed | Phase 1 | 30 | Galera Therapeutics, Inc.INDUSTRY | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02323724 | APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. | completed | — | 25 | Corporacion Parc TauliOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02527226 | Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors | completed | N/A | 76 | Mayo ClinicOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01046266 | A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 62 | Hoffmann-La RocheINDUSTRY | 5 | Sep 14, 2016 | clinicaltrials |
| NCT02049177 | Investigation of the Role of Human Papilloma Virus (HPV) in the Prognosis of Head and Neck Cancer(ARCAGE-NWE) | completed | — | 141 | University of AberdeenOTHER | 1 | Sep 8, 2016 | clinicaltrials |
| NCT00580983 | Optimized Intensity Modulated Irradiation for Head and Neck Cancer | completed | N/A | 90 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01757470 | Vandetanib Risk Minimisation Effectiveness | completed | — | 12 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00450138 | Open Label, Phase I ZD6474 Head and Neck Cancer Study | completed | Phase 1 | 48 | SanofiINDUSTRY | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01371643 | Surgical Debulking of Pituitary Adenomas | completed | Phase 4 | 41 | NYU Langone HealthOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01469546 | Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer | completed | Phase 2 | 42 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01661062 | A Study Using Cone Beam CT for Head and Neck Cancer | completed | N/A | 23 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT02505139 | The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients | completed | — | 166 | Sun Yat-sen UniversityOTHER | 0 | Aug 29, 2016 | clinicaltrials |
| NCT02880072 | Absorption of Orally Ingested Phosphate in Refeeding Syndrome | completed | Phase 4 | 12 | Jens Rikardt AndersenOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT02515084 | Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma(THYRIRMTEP) | completed | Phase 2 | 37 | Centre Henri BecquerelOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT01620138 | Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas | completed | Phase 2 / Phase 3 | 21 | Universidade Federal do Rio de JaneiroOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT01045421 | Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies | completed | Phase 1 / Phase 2 | 273 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 15, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00736619 | Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) | completed | Phase 1 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00968435 | Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02030509 | Quick Diagnostic Program for Head and Neck Cancer | completed | — | 196 | Corporacion Parc TauliOTHER | 1 | Aug 9, 2016 | clinicaltrials |
| NCT02857413 | Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy(XEROSTOMIA) | completed | — | 42 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Aug 8, 2016 | clinicaltrials |
| NCT02855723 | Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable(SentiMERORL) | completed | N/A | 307 | University Hospital, MontpellierOTHER | 1 | Aug 4, 2016 | clinicaltrials |
| NCT02854358 | Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia | completed | Phase 2 | 60 | Shiraz University of Medical SciencesOTHER | 0 | Aug 3, 2016 | clinicaltrials |
| NCT00514943 | BIBW 2992 (Afatinib) in Head & Neck Cancer | completed | Phase 2 | 124 | Boehringer IngelheimINDUSTRY | 4 | Jul 26, 2016 | clinicaltrials |
| NCT02523430 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT01204476 | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00036881 | Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | 173 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 14, 2016 | clinicaltrials |
| NCT00003610 | Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy | completed | Phase 3 | 18 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02324881 | Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy | completed | N/A | 24 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01843673 | Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer | completed | N/A | 16 | Virginia Commonwealth UniversityOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00519077 | Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 44 | University of ChicagoOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00610415 | Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study | completed | — | 40 | Stanford UniversityOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00731380 | A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer | completed | Phase 1 | 12 | University Health Network, TorontoOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT01737008 | Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 | 12 | University Health Network, TorontoOTHER | 1 | Jun 13, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Nov 23, 2016source: clinicaltrials